SST Neurons in Male Mice Medial Prefrontal Cortex Mediate Stress Resilience Through Transcriptomic Stability
Somatostatin-expressing interneurons in the medial prefrontal cortex resist stress-induced transcriptomic perturbations to mediate male resilience, according to Research square.
Selective enhancement of somatostatin interneuron activity via cell type-specific inactivation of GABAA receptors robustly promotes resilience to chronic variable stress, according to the study published on September 9, 2026. M. Shao, D. Banerjee, A. Paul and colleagues at The Pennsylvania State University examined purified somatostatin neurons from the medial prefrontal cortex of male mice, using corresponding females as negative controls.
The research team found that the transcriptome of these neurons in male mice exhibits marked resistance to chronic variable stress-induced perturbations. Following stress exposure, resilient male mice displayed a substantially reduced number of differentially expressed genes compared to vulnerable littermates. Gene set enrichment analyses indicated that these neurons are protected from stress-induced downregulation of gene sets governing neural cell fate, apoptosis, and cell adhesion.
The neural substrate underlying stress resilience is sex-specific, localizing to the medial prefrontal cortex in males and mapping to the ventral hippocampus in females, pmc.ncbi.nlm.nih.gov reported. In contrast to males, somatostatin neurons from the medial prefrontal cortex of female mice with inactivated GABAA receptors exhibited an increased number of stress-responsive differentially expressed genes, Nature reported.
Preclinical studies cited by pmc.ncbi.nlm.nih.gov indicate that somatostatin-positive interneurons regulate vulnerability to stress-related psychiatric disorders such as major depressive disorder, posttraumatic stress disorder, and schizophrenia. These interneurons preferentially innervate distal dendrites of pyramidal cells to modulate excitatory inputs, and chronic stress exposure is associated with decreased somatostatin function.